Raymond Debbane - Director at Lexicon Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Raymond Debbane since 11/23/2023

Holdings reported by Raymond Debbane for Lexicon Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.45M $14.3M $2.62 Apr 28, 2024 By Invus US Partners LLC
Common Stock 1.35M $3.53M $2.62 Apr 28, 2024 Direct
Restricted Stock Units 36.8K $96.4K $2.62 May 13, 2024 Direct Common Stock
Stock Option (Right to Buy) 44.9K May 13, 2024 Direct Common Stock

Transactions reported by Raymond Debbane for Lexicon Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.